Clinical Trial Update: Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients. [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on febuxostat for improving endothelial dysfunction in hemodialysis patients (Phase 2/3; completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Renal Disease
• Endothelial Dysfunction

Drugs mentioned

• FEBUXOSTAT (Febuxostat)

Snippet

Sponsor: Ain Shams University | Conditions: Endothelial Dysfunction, Endstage Renal Disease | Phase 2, Phase 3 | Status: COMPLETED